<p>Plasmid-Mediated AmpC β-Lactamase <em>CITM</em> and <em>DHAM</em> Genes Among Gram-Negative Clinical Isolates</p>

Abstract

High prevalence of AmpC β-lactamase-producers in our study is an alarming sign. This study recommends the use of modern diagnostic facilities in the clinical settings for early detection and management which can optimize the treatment therapies, curb the growth and spread of the drug-resistant pathogens.